← back to search

Jens Dreyhaupt

Medizinische Hochschule Hannover · DE
Area of research
Neurology · Ophthalmology
Research interest
Research interests include Medicine, Amyotrophic lateral sclerosis, Internal medicine, Placebo, Riluzole, and Gestational age.
h-index
citations
1,281
works
20
NIH funding
primary concept
email

Recent publications

Respiratory function in 192 adult patients with spinal muscular atrophy (SMA) treated with nusinersen – a multicenter observational study
Orphanet Journal of Rare Diseases 2025cited by 1position: middledoi
In‐depth analysis of data from the RAS‐ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosis
European Journal of Neurology 2024cited by 8position: middledoi
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia
Journal of Clinical Oncology 2023cited by 40position: middledoi
CSF Findings in Acute NMDAR and LGI1 Antibody–Associated Autoimmune Encephalitis
Neurology Neuroimmunology & Neuroinflammation 2021cited by 64position: middledoi
Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis
Journal of Neurology Neurosurgery & Psychiatry 2020cited by 46position: middledoi
Periodontal health in shortened dental arches: A 10-year RCT
Journal of Prosthodontic Research 2020cited by 19position: middledoi
Effect of High‐Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis
Annals of Neurology 2019cited by 162position: middledoi
Prognostic factors in ALS: a comparison between Germany and China
Journal of Neurology 2019cited by 70position: middledoi
Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment
Therapeutic Advances in Neurological Disorders 2019cited by 58position: middledoi
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial
The Lancet Neurology 2018cited by 80position: middledoi
The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy
Journal of Neurology 2018cited by 46position: middledoi
Influence of PCO<sub>2</sub> Control on Clinical and Neurodevelopmental Outcomes of Extremely Low Birth Weight Infants
Neonatology 2018cited by 24position: middledoi
Neurodevelopmental outcomes of extremely low birthweight infants randomised to different PCO<sub>2</sub> targets: the PHELBI follow-up study
Archives of Disease in Childhood Fetal & Neonatal 2017cited by 28position: middledoi
Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis
Brain 2016cited by 101position: middledoi
Permissive hypercapnia in extremely low birthweight infants (PHELBI): a randomised controlled multicentre trial
The Lancet Respiratory Medicine 2015cited by 110position: middledoi
An exploratory double‐blind, randomized clinical trial with selisistat, a <scp>SirT1</scp> inhibitor, in patients with <scp>H</scp>untington's disease
British Journal of Clinical Pharmacology 2014cited by 162position: middledoi
Comparison of inguinal hernia and asymptomatic patent processus vaginalis in term and preterm infants
Journal of Pediatric Surgery 2014cited by 48position: middledoi
Gender-related differences of inguinal hernia and asymptomatic patent processus vaginalis in term and preterm infants
Journal of Pediatric Surgery 2014cited by 23position: middledoi
A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
PLoS ONE 2012cited by 149position: middledoi
Subjective and objective results of arthroscopic debridement of ulnar-sided TFCC (Palmer type 1B) lesions with stable distal radio-ulnar joint
Archives of Orthopaedic and Trauma Surgery 2012cited by 42position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Albert C. Ludolph · German Center for Neurodegenerative Diseases7 papers (2012–2024)Thomas Meyer · University Medical Center Freiburg6 papers (2012–2024) · 6 papers (2012–2024) · 6 papers (2012–2024)Julian Großkreutz · KU Leuven6 papers (2012–2024)Jan Kassubek · Sunnybrook Health Science Centre6 papers (2012–2024)Susanne Petri · SMART Reading5 papers (2018–2024)Luc Dupuis · University of Fribourg5 papers (2012–2024)Jochen H. Weishaupt · University of Mannheim4 papers (2018–2024)Andrea Sylvia Winkler · Technical University of Munich4 papers (2012–2024)Johannes Prudlo · Johannes Gutenberg University Mainz4 papers (2018–2024) · 3 papers (2019–2024)Matthias Boentert · Ludwig-Maximilians-Universität München3 papers (2019–2024)Johannes Dorst · Johannes Gutenberg University Mainz3 papers (2019–2024) · 3 papers (2019–2024)Bertold Schrank · SMART Reading3 papers (2012–2020) · 2 papers (2012–2018) · 2 papers (2019–2020) · 2 papers (2016–2024)Joachim Schuster · LMU Klinikum2 papers (2019–2020)